Browse Products by Therapy

ZOSYN (Piperacillin and Tazobactam Injection) 4.5 g (4 gram Piperacillin/0.5 gram Tazobactam) 100 mL in GALAXY Plastic Container. Frozen Premix

Email | Print

SKU: 2G3577

ZOSYN (Piperacillin and Tazobactam Injection) 4.5 g (4 gram Piperacillin/0.5 gram Tazobactam) 100 mL in GALAXY Plastic Container. Frozen Premix NDC: 0206-8862-01 (Single Container) 0206-8862-02 (Carton)

Product information last updated Sep-23-2020

Product Characteristics

Trademark: ZOSYN is a trademark of Wyeth Holdings Corporation; Galaxy is a trademark of Baxter International Inc., or it subsidiaries.
Container Type: GALAXY
Volume: 100 ML
Drug Class: Anti-Infective
Dosage Form: Frozen
Diluent: Dextrose
Strength: 4.5 gm/100 mL
Shelf Life from manufacture: 9 months
Contains Preservative: No
Storage Recommendations: Store in a freezer capable of maintaining a temperature of -20°C (-4°F). The thawed solution is stable for 14 days under refrigeration (2°C to 8°C [36°F to 46°F]) or 24 hours at room temperature 20°C to 25°C [68°F to 77°F]. Do not refreeze.
Rx Only: Yes

Carton

Length: 12 IN
Width: 6 IN
Height: 3 IN
Volume: 0.12 FC
Weight: 3.5 LB
Pack Factor: 12

Reimbursement Information

HCPCS Code HCPCS Descriptor
J2543 INJECTION, PIPERACILLIN SODIUM/TAZOBACTAM SODIUM, 1 GRAM/0.125 GRAMS (1.125 GRAMS)
A4216 STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
Medication Delivery Reimbursement Hotline 888-338-0001
Information Source: CMS
Disclaimer: The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.